BMS-986187 is a δ-opioid receptor selective orthosteric modulator (PAM) with an EC50 of 0.03 μM and a pKB of 6.02 (~1 μM). bms-986187 has no observable PAM activity at the μ receptor (EC50=3 μM).
|Formula||C31 H34 O4|
Powder -20°C 3 years ; 4°C 2 years
In solvent -80°C 6 months ; -20°C 1 month
|Body Surface Area (m2)||0.007||0.025||0.15||0.05||0.02||0.5|
|Animal A (mg/kg) = Animal B (mg/kg) multiplied by||Animal B Km|
|Animal A Km|
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
 Jesse J DiCello, et al. Am J Physiol Gastrointest Liver Physiol. Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders
|Related Opioid Receptor Products|
Loxicodegol is a first-in-class, orally active, long-acting, selective μ-opioid agonist with structural properties that reduce its rate of crossing the blood-brain barrier compared to traditional μ-opioid agonists.
Icalcaprant is a kappa-opioid receptor antagonist.
MOR agonist-1 is a MOR (μ-opioid receptor) agonist.
Deltorphin (Deltorphin A; Dermenkephalin) is a biological active peptide.
TIPP is a potent and selective δ-opioid antagonist with a Ki value of 1.22 nM.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.